Bridgeway Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-41,060
| Closed | -$47K | – | 1484 |
|
|
2017
Q3 | $47K | Sell |
41,060
-56,205
| -58% | -$64.3K | ﹤0.01% | 1372 |
|
|
2017
Q2 | $113K | Sell |
97,265
-33,795
| -26% | -$39.3K | ﹤0.01% | 1353 |
|
|
2017
Q1 | $172K | Hold |
131,060
| – | – | ﹤0.01% | 1297 |
|
|
2016
Q4 | $275K | Hold |
131,060
| – | – | ﹤0.01% | 1246 |
|
|
2016
Q3 | $347K | Sell |
131,060
-79,800
| -38% | -$211K | 0.01% | 1202 |
|
|
2016
Q2 | $401K | Buy |
210,860
+75,000
| +55% | +$143K | 0.01% | 1138 |
|
|
2016
Q1 | $399K | Buy |
135,860
+52,800
| +64% | +$155K | 0.01% | 1132 |
|
|
2015
Q4 | $259K | Hold |
83,060
| – | – | ﹤0.01% | 1245 |
|
|
2015
Q3 | $262K | Buy |
83,060
+20,000
| +32% | +$63.1K | 0.01% | 1258 |
|
|
2015
Q2 | $240K | Buy |
63,060
+19,500
| +45% | +$74.2K | ﹤0.01% | 1314 |
|
|
2015
Q1 | $205K | Buy |
43,560
+15,300
| +54% | +$72K | ﹤0.01% | 1331 |
|
|
2014
Q4 | $180K | Buy |
+28,260
| New | +$180K | ﹤0.01% | 1324 |
|